• 3613 Citations
  • 35 Scopus h-Index
20042019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Qian D Shi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Colonic Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

Assessment of Treatment with Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients with Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial

Abou-Alfa, G. K., Shi, Q., Knox, J. J., Kaubisch, A., Niedzwiecki, D., Posey, J., Tan, B. R., Kavan, P., Goel, R., Lammers, P. E., Bekaii-Saab, T. S., Tam, V. C., Rajdev, L., Kelley, R. K., El Dika, I., Zemla, T., Potaracke, R. I., Balletti, J., El-Khoueiry, A. B., Harding, J. H. & 7 others, Suga, J. M., Schwartz, L. H., Goldberg, R. M., Bertagnolli, M. M., Meyerhardt, J., O'Reilly, E. M. & Venook, A. P., Jan 1 2019, (Accepted/In press) In : JAMA Oncology.

Research output: Contribution to journalArticle

Doxorubicin
Hepatocellular Carcinoma
Randomized Controlled Trials
Survival
Therapeutics
3 Citations (Scopus)

Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance)

Schrag, D., Weiser, M., Saltz, L., Mamon, H., Gollub, M., Basch, E., Venook, A. & Shi, Q. D., Jan 1 2019, In : Clinical Trials.

Research output: Contribution to journalArticle

Rectal Neoplasms
oxaliplatin
Recurrence
Drug Therapy
Fluorouracil

Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer

Aide et Recherche en Cancerologie Digestive Group, Sep 4 2019, In : JAMA Network Open. 2, 9, p. e1911750

Research output: Contribution to journalArticle

Open Access
Colorectal Neoplasms
Randomized Controlled Trials
Biomarkers
Survival
Neoplasms
3 Citations (Scopus)

Intertumoral heterogeneity of CD3þ and CD8þ T-cell densities in the microenvironment of DNA mismatch-repair–deficient colon cancers: Implications for prognosis

Yoon, H. H., Shi, Q. D., Heying, E. N., Muranyi, A., Bredno, J., Ough, F., Djalilvand, A., Clements, J., Bowermaster, R., Liu, W. W., Barnes, M., Alberts, S. R., Shanmugam, K. & Sinicrope, F. A., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 125-133 9 p.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Colonic Neoplasms
Cell Count
T-Lymphocytes
DNA
1 Citation (Scopus)

Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance)

Song, M., Ou, F-S., Zemla, T. J., Hull, M. A., Shi, Q. D., Limburg, P. J., Alberts, S. R., Sinicrope, F. A., Giovannucci, E. L., Van Blarigan, E. L., Meyerhardt, J. A. & Chan, A. T., Jan 1 2019, (Accepted/In press) In : International Journal of Cancer.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Omega-3 Fatty Acids
Tumor Biomarkers
Unsaturated Fatty Acids
Colonic Neoplasms